FDA Advisory Committee Recommends Approval Of Pfizer???s Proposed Biosimilar To Epogen/Procrit Across All Indications Post author:Sam Post published:May 25, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Bavarian Nordic Plummets 49% After Cancer Vaccine Flunks Late-Stage Test September 14, 2017 Backed by Amazon and Big Names Like Bristol-Myers Squibb, Celgene and Merck & Co., Bay Area's GRAIL Banks $900 Million March 1, 2017 Vedanta Biosciences Granted U.S. Patent Broadly Covering Methods Of Treatment With Therapeutics Based On Bacterial Spore Fractions Of Microbiota Obtained From Human Donors May 29, 2017
Backed by Amazon and Big Names Like Bristol-Myers Squibb, Celgene and Merck & Co., Bay Area's GRAIL Banks $900 Million March 1, 2017
Vedanta Biosciences Granted U.S. Patent Broadly Covering Methods Of Treatment With Therapeutics Based On Bacterial Spore Fractions Of Microbiota Obtained From Human Donors May 29, 2017